|
Name: 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
Type: Synthetic cannabinoid
AKA: 5F-CUMYL-PINACA; SGT-25
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
1-(5-Fluoropentyl)-N-(2-Phenylpropan-2-yl)-1H-Indazole-3-Carboxamide, a synthetic cannabinoid, was first synthesized in the 2010s. It is designed to mimic the effects of THC and interact with cannabinoid receptors. The compound's introduction reflects trends in synthetic cannabinoid development. Its health risks and potency have led to increased regulatory measures.
|
|
V. Legal Information
1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide is a synthetic cannabinoid often regulated under analog laws. In the U.S., it falls under the Federal Analog Act if it mimics controlled substances. Globally, many countries have imposed strict regulations to address the misuse of synthetic cannabinoids. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
1-(5-Fluoropentyl)-n-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide is a synthetic cannabinoid that produces effects similar to THC, including euphoria, altered perception, and increased appetite. It can lead to drowsiness, elevated heart rate, and anxiety. Overdose risks include severe agitation and cardiovascular issues. Safe use requires careful dosing. Recent research focuses on its psychoactive properties and potential for abuse.  |
|
VII. Psychological Effects
1-(5-Fluoropentyl)-n-(2-phenylpropan-2-yl)-1h-indazole-3-carboxamide is a synthetic cannabinoid causing intense euphoria and altered perception. Immediate effects include mood elevation and cognitive distortion. Long-term use can result in severe anxiety, psychosis, and cognitive impairments. Recent studies indicate high abuse potential and significant psychological risks associated with synthetic cannabinoids.
 |
|
VIII. Culture
This compound is a synthetic cannabinoid mimicking THC effects, classifying it as a downer. Short-term use induces euphoria, relaxation, and altered perception, while long-term use may lead to cognitive impairment and psychological dependence. Overdose can result in severe anxiety, hallucinations, and cardiovascular issues. Safe dosages are not well-established, with lower doses advised. Recent research highlights its abuse potential and health risks. Physical signs include red eyes, dry mouth, and altered mental state.
 |